Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial

AIMS: Biomarkers have proven their ability in the evaluation of cardiopulmonary diseases. We investigated the utility of concentrations of the biomarker procalcitonin (PCT) alone and with clinical variables for the diagnosis of pneumonia in patients presenting to emergency departments (EDs) with a c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Maisel, Alan, Neath, Sean-Xavier, Landsberg, Judd, Mueller, Christian, Nowak, Richard M., Peacock, W. Frank, Ponikowski, Piotr, Möckel, Martin, Hogan, Christopher, Wu, Alan H.B., Richards, Mark, Clopton, Paul, Filippatos, Gerasimos S., Di Somma, Salvatore, Anand, Inder, Ng, Leong L., Daniels, Lori B., Christenson, Robert H., Potocki, Mihael, McCord, James, Terracciano, Garret, Hartmann, Oliver, Bergmann, Andreas, Morgenthaler, Nils G., Anker, Stefan D.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2012
Matèries:
Diagnosis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3284113/
https://ncbi.nlm.nih.gov/pubmed/22302662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurjhf/hfr177
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars